Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Neurology

Building Your Specialized Care Team

At a Glance

Managing Familial Cerebral Cavernous Malformation (FCCM) requires a specialized team including an epileptologist, neurosurgeon, geneticist, and neuroradiologist. Receiving care at a CCM Center of Excellence ensures expert, integrated treatment and lifelong monitoring for this complex condition.

Managing Familial Cerebral Cavernous Malformation (FCCM) is a lifelong journey that requires more than just one doctor. Because FCCM can affect the brain, spine, skin, and eyes, and because it has deep genetic implications for your entire family, you need a multidisciplinary team [1][2]. This team works together to monitor your “lesion burden,” manage symptoms like seizures, and help you navigate family planning [3][4].

Your Core Specialty Team

A complete care team for FCCM typically includes these key specialists:

  • The Neurologist (Ideally an Epileptologist): Your neurologist is the “quarterback” of your care. They manage your day-to-day symptoms, such as headaches or seizures [1]. Because seizures are a common complication of FCCM, an epileptologist (a neurologist who specializes in epilepsy) is often better equipped to manage the specific type of electrical activity caused by the iron deposits in cavernomas [5][6].
  • The Neurosurgeon: While you may never need surgery, a neurosurgeon with vascular expertise is an essential partner [1]. They evaluate which lesions are “high-risk” based on their location and determine if or when a lesion needs to be removed due to repeated bleeding [7][8].
  • The Medical Geneticist: This specialist is vital for confirming the familial nature of your condition [4]. They facilitate genetic testing for the CCM1, CCM2, and CCM3 genes [9][10].
  • The Genetic Counselor: While the geneticist diagnoses the condition, the genetic counselor provides ongoing, emotional and practical support for family testing and family planning [4][11].
  • The Neuroradiologist: This is a doctor who specializes in reading brain scans. For FCCM, you need a neuroradiologist who is an expert in advanced MRI sequences like SWI and QSM [12][13]. They are the ones who can tell the difference between a stable lesion and a new micro-hemorrhage [14][15].

Why a “Center of Excellence” Matters

Because FCCM is a rare condition, many local hospitals see only a few cases a year. A CCM Center of Excellence is a hospital that has been recognized for meeting strict criteria in the care of this disease.

  • Integrated Care: At these centers, the specialists mentioned above already work together as a single team [16]. You often don’t have to explain your history over and over because they share a unified treatment philosophy [17].
  • High Volume and Expertise: Surgeons and neurologists at these centers manage hundreds of CCM patients, giving them the experience needed to handle complex cases, such as lesions in the brainstem [18][19].
  • Access to Research: These centers are often the hubs for clinical trials for new medications (like Propranolol) and maintain registries that help advance the science of FCCM [20][21].

Vetting Your Local Care

If you are not near a Center of Excellence, it is important to “audit” your current care team to ensure they are familiar with the unique needs of the familial form. A doctor who primarily treats sporadic cases may not be aware that FCCM requires lifelong imaging of both the brain and spine, or that genetic counseling is a mandatory part of the standard of care [2][22]. Building the right team is your best defense in staying ahead of the condition. For what life looks like long-term, read Long-Term Monitoring and Life with FCCM.

Common questions in this guide

What specialists should be on my FCCM care team?
A comprehensive FCCM care team typically includes a neurologist (ideally an epileptologist), a neurosurgeon, a medical geneticist, a genetic counselor, and a neuroradiologist. This team works together to monitor your lesions, manage symptoms like seizures, and help with family planning.
Why is a Center of Excellence important for cavernous malformations?
Centers of Excellence offer integrated care from specialists who manage high volumes of FCCM patients. These specialized hospitals provide expert evaluation, utilize advanced MRI techniques, and offer access to the latest clinical trials.
What is the difference in care for familial versus sporadic CCM?
Unlike sporadic cases that may involve a single lesion, the familial form of CCM requires lifelong imaging of both the brain and spine. It also requires genetic counseling and testing to understand the implications for your entire family.
Do I need a neurosurgeon if I don't need surgery right now?
Yes, having a neurosurgeon with vascular expertise on your team is essential even if you do not currently need surgery. They help evaluate the risk of your lesions based on location and monitor them over time to determine if intervention is needed due to bleeding.
What type of MRI scans do I need to monitor my FCCM?
Your doctor should be using advanced MRI sequences like Susceptibility-Weighted Imaging (SWI) and Quantitative Susceptibility Mapping (QSM). These techniques are crucial for distinguishing between stable lesions and new micro-hemorrhages.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with 'familial' (not just sporadic) cavernous malformation does this center manage annually?
  2. 2.Does the radiology department here routinely use SWI or QSM sequences for CCM monitoring?
  3. 3.Is there an epileptologist on the team who specializes in vascular-related seizures?
  4. 4.How do you coordinate care between the neurosurgeon, neurologist, and geneticist in this office?
  5. 5.What is your process for screening first-degree relatives once a genetic mutation is confirmed?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Seizure Incidence Rates in Children and Adults With Familial Cerebral Cavernous Malformations.

    Fox CK, Nelson J, McCulloch CE, et al.

    Neurology 2021; (97(12)):e1210-e1216 doi:10.1212/WNL.0000000000012569.

    PMID: 34389651
  2. 2

    Spinal involvement in pediatric familial cavernous malformation syndrome.

    Geraldo AF, Luis A, Alves CAPF, et al.

    Neuroradiology 2022; (64(8)):1671-1679 doi:10.1007/s00234-022-02958-1.

    PMID: 35451625
  3. 3

    Identification of a Novel Deletion Mutation (c.1780delG) and a Novel Splice-Site Mutation (c.1412-1G>A) in the CCM1/KRIT1 Gene Associated with Familial Cerebral Cavernous Malformation in the Chinese Population.

    Yang C, Zhao J, Wu B, et al.

    Journal of molecular neuroscience : MN 2017; (61(1)):8-15 doi:10.1007/s12031-016-0836-2.

    PMID: 27649701
  4. 4

    Molecular diagnostic workflow, clinical interpretation of sequence variants, and data repository procedures in 140 individuals with familial cerebral cavernous malformations.

    Fusco C, Copetti M, Mazza T, et al.

    Human mutation 2019; (40(11)):e24-e36 doi:10.1002/humu.23851.

    PMID: 31254430
  5. 5

    Pharmacotherapy for cavernous malformations.

    Rudy RF, Du R

    Handbook of clinical neurology 2017; (143()):309-316 doi:10.1016/B978-0-444-63640-9.00031-X.

    PMID: 28552155
  6. 6

    Safety and effectiveness of stereotactic laser ablation for epileptogenic cerebral cavernous malformations.

    Willie JT, Malcolm JG, Stern MA, et al.

    Epilepsia 2019; (60(2)):220-232 doi:10.1111/epi.14634.

    PMID: 30653657
  7. 7

    Cerebral Cavernous Malformation: What a Practicing Clinician Should Know.

    Flemming KD, Lanzino G

    Mayo Clinic proceedings 2020; (95(9)):2005-2020 doi:10.1016/j.mayocp.2019.11.005.

    PMID: 32605781
  8. 8

    Contralateral Interhemispheric Transfalcine Approach to the Basal Ganglia.

    Kalani MYS

    World neurosurgery 2024; (183()):93 doi:10.1016/j.wneu.2023.12.066.

    PMID: 38123129
  9. 9

    Familial cerebral cavernous malformation presenting with epilepsy caused by mutation in the CCM2 gene: A case report.

    Ishii K, Tozaka N, Tsutsumi S, et al.

    Medicine 2020; (99(29)):e19800 doi:10.1097/MD.0000000000019800.

    PMID: 32702807
  10. 10

    Hereditary Haemorrhagic Cerebrovascular Disease: Implications for Clinical Management.

    Hou W, Hou Y, Ren X, Liu J

    Annals of neurosciences 2025; 09727531241308346 doi:10.1177/09727531241308346.

    PMID: 40115281
  11. 11

    Quality of life and mood assessment in conservatively treated cavernous malformation-related epilepsy.

    Rauschenbach L, Bartsch P, Santos AN, et al.

    Brain and behavior 2022; (12(6)):e2595 doi:10.1002/brb3.2595.

    PMID: 35470577
  12. 12

    Asymptomatic Familial Multiple Cerebral Cavernous Malformation in a 73-Year-Old Woman.

    Dzefi-Tettey K, Edzie EKM, Gorleku PN, et al.

    Case reports in radiology 2021; (2021()):9974776 doi:10.1155/2021/9974776.

    PMID: 34094613
  13. 13

    Cavernous Angioma: A Rare Cause of Multiple Cranial Nerve Palsies.

    Karthikeyan Meenakshi K, S M, Sekhar CHN, et al.

    Cureus 2024; (16(8)):e67464 doi:10.7759/cureus.67464.

    PMID: 39310500
  14. 14

    Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage.

    Zeineddine HA, Girard R, Cao Y, et al.

    Journal of magnetic resonance imaging : JMRI 2018; (47(4)):1133-1138 doi:10.1002/jmri.25831.

    PMID: 28791783
  15. 15

    Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations.

    Tan H, Zhang L, Mikati AG, et al.

    AJNR. American journal of neuroradiology 2016; (37(7)):1209-15 doi:10.3174/ajnr.A4724.

    PMID: 26965464
  16. 16

    Clinicoradiologic data of familial cerebral cavernous malformation with age-related disease burden.

    Kim S, Moon J, Jung KH, et al.

    Annals of clinical and translational neurology 2023; (10(3)):373-383 doi:10.1002/acn3.51728.

    PMID: 36629374
  17. 17

    Tuberous sclerosis with negative genetic testing and multiple cerebral cavernomas: A new association (Case report).

    Arbune AA, Toron BR, Lupescu IC, et al.

    Experimental and therapeutic medicine 2021; (22(4)):1183 doi:10.3892/etm.2021.10617.

    PMID: 34475973
  18. 18

    Surgery for cerebral cavernous malformations: a systematic review and meta-analysis.

    Harris L, Poorthuis MHF, Grover P, et al.

    Neurosurgical review 2022; (45(1)):231-241 doi:10.1007/s10143-021-01591-5.

    PMID: 34191202
  19. 19

    Clinical course of patients with conservatively managed cerebral cavernous malformations.

    Sandmann ACA, Kempeneers MA, van den Berg R, et al.

    European stroke journal 2024; (9(3)):667-675 doi:10.1177/23969873241246868.

    PMID: 38624046
  20. 20

    Cerebral Cavernous Malformation: From Mechanism to Therapy.

    Snellings DA, Hong CC, Ren AA, et al.

    Circulation research 2021; (129(1)):195-215 doi:10.1161/CIRCRESAHA.121.318174.

    PMID: 34166073
  21. 21

    Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial.

    The Lancet. Neurology 2024; (23(6)):565-576 doi:10.1016/S1474-4422(24)00096-6.

    PMID: 38643777
  22. 22

    Exome capture sequencing identifies a novel CCM1 mutation in a Chinese family with multiple cerebral cavernous malformations.

    Mao CY, Yang J, Zhang SY, et al.

    The International journal of neuroscience 2016; (126(12)):1071-6 doi:10.3109/00207454.2015.1118628.

    PMID: 26643368

This page provides educational information about building a specialized care team for FCCM. Always consult your healthcare provider or a recognized Center of Excellence for personalized medical advice and treatment.

Get notified when new evidence is published on Familial cerebral cavernous malformation.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.